Medtronic, Inc.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$97.2M

Filings

450

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$3,730,000	9	3
2025	$4,690,000	12	3
2024	$4,290,000	16	4
2023	$3,760,000	16	4
2022	$3,729,650	20	5
2021	$5,093,000	20	5
2020	$5,003,000	20	5
2019	$4,879,000	33	9
2018	$4,780,000	29	7
2017	$3,710,000	28	7
2016	$4,396,000	23	6
2015	$4,011,000	27	7
2014	$6,790,000	21	5
2013	$6,180,000	17	4
2012	$4,900,000	20	5
2011	$8,659,620	23	5
2010	$4,069,018	17	5
2009	$4,194,000	19	5
2008	$5,136,000	22	5
2007	$1,700,000	12	5
2006	$2,060,000	8	4
2005	—	5	3
2004	$480,000	3	3
2003	$340,000	7	4
2002	$240,000	6	4
2001	$160,000	8	4
2000	$60,000	2	2
1999	$160,000	7	3

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
Medtronic, Inc.	$97,200,288	96
W STRATEGIES, LLC	—	66
BROWN RUDNICK LLP	—	49
MEHLMAN CONSULTING, INC.	—	32
AKIN GUMP STRAUSS HAUER FELD	—	51
ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)	—	40
HEALTH POLICY ALTERNATIVES	—	22
BREAUX LOTT LEADERSHIP GROUP	—	7
DUTKO WORLDWIDE, LLC	—	18
GOVERNMENT COUNSEL, LLC	—	25
HALE & DORR	—	7
CROWELL & MORING LLP	—	13
FOLEY HOAG LLP	—	7
10-SQUARE SOLUTIONS	—	10
NIXON PEABODY, LLP	—	7

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	375
SENATE	339
Centers For Medicare and Medicaid Services (CMS)	45
Health & Human Services, Dept of (HHS)	37
Executive Office of the President (EOP)	23
Food & Drug Administration (FDA)	19
Commerce, Dept of (DOC)	13
White House Office	12
Office of Management & Budget (OMB)	10
U.S. Trade Representative (USTR)	8
Veterans Affairs, Dept of (VA)	7
Office of the Vice President of the United States	6
Defense, Dept of (DOD)	5
Treasury, Dept of	5
Environmental Protection Agency (EPA)	3
Office of Science & Technology Policy (OSTP)	3
Transportation, Dept of (DOT)	3
Justice, Dept of (DOJ)	2
Securities & Exchange Commission (SEC)	2
State, Dept of (DOS)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	338
Medicare/Medicaid	Medicare/Medicaid	216
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	192
Trade (domestic/foreign)	Trade (domestic/foreign)	119
Budget/Appropriations	Budget/Appropriations	79
Copyright/Patent/Trademark	Copyright/Patent/Trademark	76
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	73
Veterans	Veterans	57
Telecommunications	Telecommunications	51
Environment/Superfund	Environment/Superfund	38
Transportation	Transportation	32
Government Issues	Government Issues	29
Aviation/Airlines/Airports	Aviation/Airlines/Airports	23
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	20
Defense	Defense	18
Education	Education	17
Immigration	Immigration	15
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	9
Pharmacy	Pharmacy	8
Homeland Security	Homeland Security	8

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1539119th Congress

Medical Device Electronic Labeling Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 1539

H.R. 2683119th Congress

Remote Access Security Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to supply chain resiliency including memory chip shortages Issues related to data and the cloud including H.R. 2683/S. 3519, the Remote Access Security Act Issues related to tariffs Issues related to the renewal of USMCA Issues related to secondary tariff authority under PL 119-111, the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 2683

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD Issues related to CY2027 OPPS/ASC Proposed Rule and multiple procedure reduction Issues related to CY2027 Physician Fee Schedule Proposed Rule and Modifier 25 payment reduction

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 5343

H.R. 6197119th Congress

Health Tech Investment Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD Issues related to CY2027 OPPS/ASC Proposed Rule and multiple procedure reduction Issues related to CY2027 Physician Fee Schedule Proposed Rule and Modifier 25 payment reduction

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 6197

Show 21 more cited filings

H.R. 8413119th Congress

SECURE Data Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to data privacy and data security, including H.R. 8413, the Securing and Establishing Uniform Rights and Enforcement over Data Act Issues related to artificial intelligence enabled medical devices and emerging technologies, including H.R. 9924, the FRONTIER Act Issues related to right to repair

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 8413

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the issuance of dividends, including provisions of H.R. 8800/S.4784, the National Defense Authorization Act of 2027

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 8800

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 8800

H.R. 9924119th Congress

Local Input Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to data privacy and data security, including H.R. 8413, the Securing and Establishing Uniform Rights and Enforcement over Data Act Issues related to artificial intelligence enabled medical devices and emerging technologies, including H.R. 9924, the FRONTIER Act Issues related to right to repair

Client expense: $1,610,000 · Firm income: —

Matched citations: H.R. 9924

S. 1399119th Congress

Health Tech Investment Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD Issues related to CY2027 OPPS/ASC Proposed Rule and multiple procedure reduction Issues related to CY2027 Physician Fee Schedule Proposed Rule and Modifier 25 payment reduction

Client expense: $1,610,000 · Firm income: —

Matched citations: S. 1399

S. 1546119th Congress

Patent Eligibility Restoration Act of 2025

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025 Issues related to Patent Trial and Appeal Board procedures

Client expense: $1,610,000 · Firm income: —

Matched citations: S.1546

S. 1553119th Congress

PREVAIL Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025 Issues related to Patent Trial and Appeal Board procedures

Client expense: $1,610,000 · Firm income: —

Matched citations: S. 1553

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD Issues related to CY2027 OPPS/ASC Proposed Rule and multiple procedure reduction Issues related to CY2027 Physician Fee Schedule Proposed Rule and Modifier 25 payment reduction

Client expense: $1,610,000 · Firm income: —

Matched citations: S. 1717

S. 3519119th Congress

Remote Access Security Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to supply chain resiliency including memory chip shortages Issues related to data and the cloud including H.R. 2683/S. 3519, the Remote Access Security Act Issues related to tariffs Issues related to the renewal of USMCA Issues related to secondary tariff authority under PL 119-111, the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026

Client expense: $1,610,000 · Firm income: —

Matched citations: S. 3519

S. 3658119th Congress

SHIFT Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to supply chain resiliency including memory chip shortages Issues related to data and the cloud including H.R. 2683/S. 3519, the Remote Access Security Act Issues related to tariffs Issues related to the renewal of USMCA Issues related to secondary tariff authority under PL 119-111, the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026

Client expense: $1,610,000 · Firm income: —

Matched citations: S.3658

S. 4519119th Congress

Medical Device Electronic Labeling Act

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,610,000 · Firm income: —

Matched citations: S. 4519

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the issuance of dividends, including provisions of H.R. 8800/S.4784, the National Defense Authorization Act of 2027

Client expense: $1,610,000 · Firm income: —

Matched citations: S.4784

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,610,000 · Firm income: —

Matched citations: S.4784

S. 708119th Congress

RESTORE Patent Rights Act of 2025

2026 · third_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025 Issues related to Patent Trial and Appeal Board procedures

Client expense: $1,610,000 · Firm income: —

Matched citations: S.708

H.R. 1539119th Congress

Medical Device Electronic Labeling Act

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 1539

H.R. 2683119th Congress

Remote Access Security Act

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to data and the cloud including H.R. 2683/S. 3519, the Remote Access Security Act Issues related to tariffs Issues related to the renewal of USMCA

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 2683

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 5343

H.R. 6197119th Congress

Health Tech Investment Act

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 6197

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to medical device electronic labeling, including H.R. 1539/S. 4519 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including related to H.R. 8800/S.4784, the National Defense Authorization Act of 2027 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to epilepsy Issues related to overactive bladder and urinary incontinence Issues related to pelvic venous disorder (PeVD) Issues related to the medical supply chain

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 8800

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the issuance of dividends, including provisions of H.R. 8800/S.4784, the National Defense Authorization Act of 2027

Client expense: $1,180,000 · Firm income: —

Matched citations: H.R. 8800

S. 1399119th Congress

Health Tech Investment Act

2026 · second_quarter · Firm: Medtronic, Inc.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) and CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway proposal Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to non-opioid pain therapies Issues related to transcatheter heart valve NCD

Client expense: $1,180,000 · Firm income: —

Matched citations: S. 1399

Source: Senate LDA

Medtronic, Inc. — Lobbying Disclosure | Poliscope